Simultaneous PML-IRIS and myelitis in a patient with neuromyelitis optica spectrum disorder
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published September 6, 2013.
Article Versions
- Previous version (September 6, 2013 - 14:34).
- You are viewing the most recent version of this article.
Author Disclosures
- Eoin P. Flanagan, MBBCh,
- Allen J. Aksamit, MD,
- Neeraj Kumar, MD,
- Neha P. Morparia, MD,
- B. Mark Keegan, MD and
- Brian G. Weinshenker, MD
- Eoin P. Flanagan, MBBCh,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Allen J. Aksamit, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Neeraj Kumar, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Neha P. Morparia, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- B. Mark Keegan, MD and
NONE
NONE
NONE
(1)eMedicine Chief Editor 2009-present
NONE
NONE
NONE
Consulted for Bristol Myers Squibb, Novartis, and Bionest
NONE
NONE
NONE
Terumo BCT, Caridian BCT
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Brian G. Weinshenker, MD
(1) Novartis data safety monitoring board member (2) Biogen Idec data safety monitoring board member (3) Mitsubishi Pharmaceuticals data safety monitoring board member
NONE
NONE
1. Canadian Journal of Neurological Sciences, editorial board member, 2006-present; no compensation 2. Turkish Journal of Neurology, editorial board member, 2005-present; no compensation 3. Multiple Sclerosis, editorial board member, 2010- present; no compensation
1) NMO-IgG for diagnosis of neuromyelitis optica; application 20050112116; patent issued and technology licensed to R.S.R. Ltd.
NONE
NONE
(1) Elan Pharmaceuticals (2) GlaxoSmithKline Pharmaceuticals (3) Ono Pharmaceuticals (4) Asahi Kasei Medical Company
NONE
NONE
NONE
NONE
NONE
NONE
Guthy Jackson Charitable Foundation, sponsor of research in NMO, 10/2008-09/2011
NONE
NONE
NMO-IgG for diagnosis of neuromyelitis optica; patent issued and technology licensed to R.S.R. Ltd.
NONE
NONE
NONE
- Correspondence to:
weinb{at}mayo.edu
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.